Pharmaceutical News and Articles

Lecanemab for Alzheimer Disease Safe, Feasible in Real-World Practice

Treatment of Alzheimer disease with lecanemab is feasible in a specialty memory clinic, and the frequency of significant adverse events is similar to clinical t

Gabapentinoids Not Directly Associated With Risk of Self-Harm

Gabapentinoids are not associated with risk of self-harm in adults however, elevated risk is seen before initiation of treatment, during the initial phase of tr

Preinjury Mobility Predicts Adults' Recovery After Lower-Extremity Fracture

Preinjury mobility data predicts recovery following a lower-extremity fracture in adults, according to a proof-of-concept study published online April 28 in the

Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity, accor

Improvements In Prostate Cancer Tracking Help Men Stay In Active Surveillance

THURSDAY, May 15, 2025 Men in watchful waiting mode for their low-risk prostate cancer are staying healthier longer thanks to advanced imaging and treatments de

Broken Heart Syndrome Remains A Killer, Especially For Men

THURSDAY, May 15, 2025 Broken heart syndrome sounds like a romantic, fairy-tale notion the idea that suffering a devastating loss that can cause one s heart to

Smartphones Aid Recovery From Broken Leg, Hip

THURSDAY, May 15, 2025 A person s smartphone can show how well they ll recover from a broken leg or hip, a new study says. Smartphone data showing a person s mo

Alzheimer’s Drug Can Be Safely Administered In Memory Clinics, Study Says

THURSDAY, May 15, 2025 The 2023 approval of the first drug shown to slow the progression of Alzheimer s disease came with no small amount of concern from skepti

Study Finds No Link Between COVID Vaccine And Miscarriage Risk

THURSDAY, May 15, 2025 There s no link between the COVID-19 vaccine and miscarriage, a new study says. COVID poses significant risks to pregnant women, includin

FDA Approves Merck’s Welireg (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)